Full-size Left-side Hidden
REFERENCES

1. Hoare CA: Comparative aspects of human babesiosis. Trans R Soc Trop Med Hyg  1980; 74:143-148.

2. Telford III SR, Gorenflot A, Brasseur P, et al: Babesial infections in man and wildlife.   In: Kreier JP, Baker JR, ed. Parasitic Protozoa 5,  2nd edn.. San Diego: Academic Press; 1993:1-47.

3. Thomford JW, Conrad PA, Telford SR, et al: Cultivation and phylogenetic characterisation of a newly recognised human pathogenic protozoan. J Infect Dis  1994; 169:1050-1056.

4. Conrad PA, Kjemtrup AM, Carreno RA, et al: Description of Babesia duncani n.sp. (Apicomplexa: Babesiidae) from humans and its differentiation from other piroplasms. Int J Parasitol  2006; 36(7):779-789.

5. Herwaldt B, Persing DH, Precigout EA, et al: A fatal case of babesiosis in Missouri: identification of another piroplasm that infects humans. Ann Intern Med  1997; 124:643-650.

6. Herwaldt BL, de Bruyn G, Pieniazek NJ, et al: Babesia divergens-like infection, Washington State. Emerg Infect Dis  2004; 10(4):622-629.

7. Herwaldt BL, Caccio S, Gherlinzoni F, et al: Molecular characterization of a non-Babesia divergens organism causing zoonotic babesiosis in Europe. Emerg Infect Dis  2003; 9(8):942-948.

8. Shih CM, Liu LP, Chung WC, et al: Human babesiosis in Taiwan: asymptomatic infection with a Babesia microti-like organism in a Taiwanese woman. J Clin Microbiol  1997; 35:450-454.

9. Gray JS: Identity of the causal agents of human babesiosis in Europe. Int J Med Microbiol  2006; 296(Suppl 40):131-136.

10. Sinski E, Bajer A, Welc R, et al: Babesia microti: prevalence in wild rodents and Ixodes ricinus ticks from the Mazury Lakes District of North-Eastern Poland. Int J Med Microbiol  2006; 296(Suppl 40):137-143.

11. Kakoma I, Mehlhorn H: Babesia of domestic animals.   In: Kreier JP, ed. Parasitic Protozoa,  2nd edn.. San Diego: Academic Press; 1993:141-216.

12. Uilenberg G: Babesia - a historical overview. Vet Parasitol  2006; 138(1-2):3-10.

13. Berry A, Morassin B, Kamar N, et al: Clinical picture: human babesiosis. Lancet  2001; 357:341.

14. Kjemtrup AM, Conrad PA: Human babesiosis: an emerging tick-borne disease. Int J Parasitol  2000; 30:1323-1337.

15. Meldrum SC, Birkhead GS, White DJ, et al: Human babesiosis in New York State: an epidemiological description of 136 cases. Clin Infect Dis  1992; 15:1019-1023.

16. Steketee RW, Eckman MR, Burgess EC, et al: Babesiosis in Wisconsin: a new focus of disease transmission. JAMA  1985; 253:2675-2678.

17. Ruebush II TK: Human babesiosis in North America. Trans R Soc Trop Med Hyg  1980; 74:149-152.

18. Leiby DA: Babesiosis and blood transfusion: flying under the radar. Vox Sang  2006; 90(3):157-165.

19. Leiby DA, Chung AP, Gill JE, et al: Demonstrable parasitemia among Connecticut blood donors with antibodies to Babesia microti. Transfusion  2005; 45(11):1804-1810.

20. Krause PJ, Telford III SR, Spielman A, et al: Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness. JAMA  1996; 275:1657-1660.

21. Swanson SJ, Neitzel D, Reed KD, et al: Coinfections acquired from ixodes ticks. Clin Microbiol Rev  2006; 19(4):708-727.

22. Benach JL, Habicht GS: Clinical characteristics of human babesiosis. J Infect Dis  1981; 144:481.

23. Ong KR, Stavropoulos C, Inada Y: Babesiosis, asplenia and AIDS. Lancet  1990; 336:112.

24. Falagas ME, Klempner MS: Babesiosis in patients with AIDS: a chronic infection presenting as fever of unknown origin. Clin Infect Dis  1996; 22:809-812.

25. Williams H: Human babesiosis. Trans R Soc Trop Med Hyg  1980; 74:157.

26. Uhnoo I, Cars O, Christensson D, et al: First documented case of human babesiosis in Sweden. Scand J Infect Dis  1992; 24:541-547.

27. Homer MJ, Aguilar-Delfin I, Telford III SR, et al: Babesiosis. Clin Microbiol Rev  2000; 13:451-469.

28. Sun T, Tenenbaum MJ, Greenspan J, et al: Morphologic and clinical observations in human infection with Babesia microti. J Infect Dis  1983; 148:239-248.

29. Benach JL, Habicht GS, Hamburger MI: Immunoresponsiveness in acute babesiosis in humans. J Infect Dis  1982; 146:369-380.

30. Hatcher JC, Greenberg PD, Antique J, et al: Severe babesiosis in Long Island: review of 34 cases and their complications. Clin Infect Dis  2001; 32:1117-1125.

31. Clark IA, Budd AC, Hsue G, et al: Absence of erythrocyte sequestration in a case of babesiosis in a splenectomised human patient. Malar J  2006; 5:69.

32. Ruebush II TK, Juranek DD, Chisholm ES, et al: Human babesiosis on Nantucket Island. Evidence for self-limited and subclinical infections. N Engl J Med  1977; 297:825-827.

33. Krause PJ, Telford SR, Ryan R, et al: Diagnosis of babesiosis: evaluation of a serologic test for the detection of Babesia microti antibody. J Infect Dis  1994; 169:923-926.

34. Loa CC, Adelson ME, Mordechai E, et al: Serological diagnosis of human babesiosis by IgG enzyme-linked immunosorbent assay. Curr Microbiol  2004; 49(6):385-389.

35. Persing DH, Mathiesen D, Marshall WF, et al: Detection of Babesia microti by polymerase chain reaction. J Clin Microbiol  1992; 30:2097-2103.

36. Raoult D, Soulayrol L, Toga B, et al: Babesiosis, pentamidine and cotrimaxozole. Ann Intern Med  1987; 107:944.

37. Vial HJ, Gorenflot A: Chemotherapy against babesiosis. Vet Parasitol  2006; 138(1-2):147-160.

38. Brasseur P, Gorenflot A: Human babesiosis in Europe. Mem Inst Oswaldo Cruz  1992; 87:131-132.

39. Pudney M, Gray JS: Therapeutic efficacy of atovaquone against the bovine intraerythrocytic parasite, Babesia divergens. J Parasitol  1997; 83:307-310.

40. Gelfand JA, Poutsiaka D: Babesia.   In: Mandell GL, Bennett JE, Dolin R, ed. Principles and Practice of Infectious Diseases,  5th edn.. Philadelphia: Churchill Livingstone; 2000:2899-2902.

41. Anonymous : Clindamycin and quinine treatment for Babesia microti infections. MMWR Morb Mortal Wkly Rep  1983; 32:65-71.

42. Krause PJ, Lepore T, Sikand VK, et al: Atovaquone and azithromycin for the treatment of babesiosis. N Engl J Med  2000; 343:1454-1458.

43. Weiss LM, Wittner M, Tanowitz HB: The treatment of babesiosis. N Engl J Med  2001; 344:773.

44. Wormser GP, Dattwyler RJ, Shapiro ED, et al: Single-dose prophylaxis against Lyme disease. Lancet Infect Dis  2007; 7(6):371-373.

45. Ranque S: The treatment of babesiosis. N Engl J Med  2001; 344:773-774.

46. Ruebush II TK, Rubin RH, Wolpow ER, et al: Neurologic complications following the treatment of human Babesia microti infection with diminazene aceturate. Am J Trop Med Hyg  1979; 28:184-189.

47. Evenson DA, Perry E, Kloster B, et al: Therapeutic apheresis for babesiosis. J Clin Apheresis  1998; 13:32-36.